2021 annual financial data
Denali Therapeutics 2021 Operating margin
Denali Therapeutics 2021 operating margin with verified reported values.
Direct answer
Operating margin was -607.78%.
Operating income was -295,751,000 USD and net income was -290,581,000 USD.
Operating cash flow was -211,389,000 USD.
Verified data
- Revenue
- 48,661,000 USD
- Operating income
- -295,751,000 USD
- Net income
- -290,581,000 USD
- Operating cash flow
- -211,389,000 USD